Dimensional Fund Advisors’s AnaptysBio ANAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-31,571
Closed -$587K 3274
2025
Q1
$587K Sell
31,571
-37
-0.1% -$617 ﹤0.01% 2979
2024
Q4
$418K Sell
31,608
-64,364
-67% -$1.56M ﹤0.01% 3066
2024
Q3
$3.22M Sell
95,972
-239,962
-71% -$8.2M ﹤0.01% 2663
2024
Q2
$8.42M Sell
335,934
-133,926
-29% -$3.12M ﹤0.01% 2330
2024
Q1
$10.6M Sell
469,860
-128,032
-21% -$3.03M ﹤0.01% 2288
2023
Q4
$12.8M Sell
597,892
-88,569
-13% -$1.53M ﹤0.01% 2209
2023
Q3
$12.3M Sell
686,461
-218,451
-24% -$4.17M ﹤0.01% 2146
2023
Q2
$18.4M Sell
904,912
-53,748
-6% -$1.09M 0.01% 1977
2023
Q1
$20.9M Buy
958,660
+16,528
+2% +$402K 0.01% 1887
2022
Q4
$29.2K Buy
942,132
+58,118
+7% +$1.64M 0.01% 1667
2022
Q3
$22.6M Sell
884,014
-38,927
-4% -$912K 0.01% 1753
2022
Q2
$18.7M Buy
922,941
+31,090
+3% +$689K 0.01% 1903
2022
Q1
$22.1M Buy
891,851
+88,457
+11% +$2.68M 0.01% 1917
2021
Q4
$27.9M Buy
803,394
+47,902
+6% +$1.52M 0.01% 1795
2021
Q3
$20.5M Sell
755,492
-16,625
-2% -$422K 0.01% 1992
2021
Q2
$20M Buy
772,117
+116,405
+18% +$2.79M 0.01% 2043
2021
Q1
$14.1M Buy
655,712
+69,160
+12% +$1.75M ﹤0.01% 2180
2020
Q4
$12.6M Buy
586,552
+13,825
+2% +$336K ﹤0.01% 2188
2020
Q3
$8.45M Buy
572,727
+18,139
+3% +$327K ﹤0.01% 2272
2020
Q2
$12.4M Buy
554,588
+7,367
+1% +$135K 0.01% 2118
2020
Q1
$7.73M Buy
547,221
+113,647
+26% +$1.72M ﹤0.01% 2229
2019
Q4
$7.04M Buy
433,574
+134,627
+45% +$3.18M ﹤0.01% 2491
2019
Q3
$10.5M Buy
298,947
+49,668
+20% +$2.36M ﹤0.01% 2323
2019
Q2
$14.1M Buy
249,279
+57,125
+30% +$4.11M 0.01% 2237
2019
Q1
$14M Buy
192,154
+112,442
+141% +$7.76M 0.01% 2243
2018
Q4
$5.08M Buy
+79,712
New +$5.93M ﹤0.01% 2607

Other funds holding ANAB

Dimensional Fund Advisors's ANAB Position: Q2 2025 in Review

Dimensional Fund Advisors sold out of AnaptysBio (ANAB) in Q2 2025, closing a stake of 31,571 shares — an estimated $587K sold.

Dimensional Fund Advisors first reported a position in ANAB in Q4 2018 and held it in 26 quarters. The position peaked at $27.9M in Q4 2021. 147 funds tracked by Wall St. Rank hold ANAB as of Q2 2025.

  • Dimensional Fund Advisors reported no remaining AnaptysBio position as of Q2 2025 after selling out during the quarter.
  • Dimensional Fund Advisors sold 31,571 AnaptysBio shares in Q2 2025, an estimated $587K.
  • Dimensional Fund Advisors first reported a position in AnaptysBio in Q4 2018 and held it in 26 quarters.
  • Dimensional Fund Advisors's AnaptysBio position peaked at $27.9M in Q4 2021.
  • 147 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2025.

Based on Dimensional Fund Advisors's 13F filing for Q2 2025, filed 12 Aug 2025.